<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2001-06-01" modified="2020-10-07" version="196">
<accession>Q06265</accession>
<accession>Q12883</accession>
<accession>Q4W5P5</accession>
<accession>Q86Y41</accession>
<accession>Q86Y48</accession>
<name>EXOS9_HUMAN</name>
<protein>
<recommendedName>
<fullName>Exosome complex component RRP45</fullName>
</recommendedName>
<alternativeName>
<fullName>Autoantigen PM/Scl 1</fullName>
</alternativeName>
<alternativeName>
<fullName>Exosome component 9</fullName>
</alternativeName>
<alternativeName>
<fullName>P75 polymyositis-scleroderma overlap syndrome-associated autoantigen</fullName>
</alternativeName>
<alternativeName>
<fullName>Polymyositis/scleroderma autoantigen 1</fullName>
</alternativeName>
<alternativeName>
<fullName>Polymyositis/scleroderma autoantigen 75 kDa</fullName>
<shortName>PM/Scl-75</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">EXOSC9</name>
<name type="synonym">PMSCL1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1991" name="J. Exp. Med." volume="173" first="941" last="952">
<title>Molecular characterization of an autoantigen of PM-Scl in the polymyositis/scleroderma overlap syndrome: a unique and complete human cDNA encoding an apparent 75-kD acidic protein of the nucleolar complex.</title>
<authorList>
<person name="Alderuccio F."/>
<person name="Chan E.K.L."/>
<person name="Tan E.M."/>
</authorList>
<dbReference type="PubMed" id="2007859"/>
<dbReference type="DOI" id="10.1084/jem.173.4.941"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3)</scope>
<source>
<tissue>Lymphoblastoma</tissue>
</source>
</reference>
<reference key="2">
<citation type="submission" date="1994-04" db="EMBL/GenBank/DDBJ databases">
<title>Nucleotide sequence of an alternatively spliced cDNA coding for PM-Scl-75, an autoantigen of the Polymyositis/Scleroderma overlap syndrome.</title>
<authorList>
<person name="Stahnke G."/>
<person name="Haubruck H."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4)</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="30698" last="30704">
<title>The association of the human PM/Scl-75 autoantigen with the exosome is dependent on a newly identified N terminus.</title>
<authorList>
<person name="Raijmakers R."/>
<person name="Egberts W.V."/>
<person name="van Venrooij W.J."/>
<person name="Pruijn G.J."/>
</authorList>
<dbReference type="PubMed" id="12788944"/>
<dbReference type="DOI" id="10.1074/jbc.m302488200"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2)</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>IDENTIFICATION IN THE RNA EXOSOME COMPLEX</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2005" name="Nature" volume="434" first="724" last="731">
<title>Generation and annotation of the DNA sequences of human chromosomes 2 and 4.</title>
<authorList>
<person name="Hillier L.W."/>
<person name="Graves T.A."/>
<person name="Fulton R.S."/>
<person name="Fulton L.A."/>
<person name="Pepin K.H."/>
<person name="Minx P."/>
<person name="Wagner-McPherson C."/>
<person name="Layman D."/>
<person name="Wylie K."/>
<person name="Sekhon M."/>
<person name="Becker M.C."/>
<person name="Fewell G.A."/>
<person name="Delehaunty K.D."/>
<person name="Miner T.L."/>
<person name="Nash W.E."/>
<person name="Kremitzki C."/>
<person name="Oddy L."/>
<person name="Du H."/>
<person name="Sun H."/>
<person name="Bradshaw-Cordum H."/>
<person name="Ali J."/>
<person name="Carter J."/>
<person name="Cordes M."/>
<person name="Harris A."/>
<person name="Isak A."/>
<person name="van Brunt A."/>
<person name="Nguyen C."/>
<person name="Du F."/>
<person name="Courtney L."/>
<person name="Kalicki J."/>
<person name="Ozersky P."/>
<person name="Abbott S."/>
<person name="Armstrong J."/>
<person name="Belter E.A."/>
<person name="Caruso L."/>
<person name="Cedroni M."/>
<person name="Cotton M."/>
<person name="Davidson T."/>
<person name="Desai A."/>
<person name="Elliott G."/>
<person name="Erb T."/>
<person name="Fronick C."/>
<person name="Gaige T."/>
<person name="Haakenson W."/>
<person name="Haglund K."/>
<person name="Holmes A."/>
<person name="Harkins R."/>
<person name="Kim K."/>
<person name="Kruchowski S.S."/>
<person name="Strong C.M."/>
<person name="Grewal N."/>
<person name="Goyea E."/>
<person name="Hou S."/>
<person name="Levy A."/>
<person name="Martinka S."/>
<person name="Mead K."/>
<person name="McLellan M.D."/>
<person name="Meyer R."/>
<person name="Randall-Maher J."/>
<person name="Tomlinson C."/>
<person name="Dauphin-Kohlberg S."/>
<person name="Kozlowicz-Reilly A."/>
<person name="Shah N."/>
<person name="Swearengen-Shahid S."/>
<person name="Snider J."/>
<person name="Strong J.T."/>
<person name="Thompson J."/>
<person name="Yoakum M."/>
<person name="Leonard S."/>
<person name="Pearman C."/>
<person name="Trani L."/>
<person name="Radionenko M."/>
<person name="Waligorski J.E."/>
<person name="Wang C."/>
<person name="Rock S.M."/>
<person name="Tin-Wollam A.-M."/>
<person name="Maupin R."/>
<person name="Latreille P."/>
<person name="Wendl M.C."/>
<person name="Yang S.-P."/>
<person name="Pohl C."/>
<person name="Wallis J.W."/>
<person name="Spieth J."/>
<person name="Bieri T.A."/>
<person name="Berkowicz N."/>
<person name="Nelson J.O."/>
<person name="Osborne J."/>
<person name="Ding L."/>
<person name="Meyer R."/>
<person name="Sabo A."/>
<person name="Shotland Y."/>
<person name="Sinha P."/>
<person name="Wohldmann P.E."/>
<person name="Cook L.L."/>
<person name="Hickenbotham M.T."/>
<person name="Eldred J."/>
<person name="Williams D."/>
<person name="Jones T.A."/>
<person name="She X."/>
<person name="Ciccarelli F.D."/>
<person name="Izaurralde E."/>
<person name="Taylor J."/>
<person name="Schmutz J."/>
<person name="Myers R.M."/>
<person name="Cox D.R."/>
<person name="Huang X."/>
<person name="McPherson J.D."/>
<person name="Mardis E.R."/>
<person name="Clifton S.W."/>
<person name="Warren W.C."/>
<person name="Chinwalla A.T."/>
<person name="Eddy S.R."/>
<person name="Marra M.A."/>
<person name="Ovcharenko I."/>
<person name="Furey T.S."/>
<person name="Miller W."/>
<person name="Eichler E.E."/>
<person name="Bork P."/>
<person name="Suyama M."/>
<person name="Torrents D."/>
<person name="Waterston R.H."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="15815621"/>
<dbReference type="DOI" id="10.1038/nature03466"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1999" name="Genes Dev." volume="13" first="2148" last="2158">
<title>The yeast exosome and human PM-Scl are related complexes of 3'--&gt;5' exonucleases.</title>
<authorList>
<person name="Allmang C."/>
<person name="Petfalski E."/>
<person name="Podtelejnikov A."/>
<person name="Mann M."/>
<person name="Tollervey D."/>
<person name="Mitchell P."/>
</authorList>
<dbReference type="PubMed" id="10465791"/>
<dbReference type="DOI" id="10.1101/gad.13.16.2148"/>
</citation>
<scope>CHARACTERIZATION</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2001" name="Cell" volume="107" first="451" last="464">
<title>AU binding proteins recruit the exosome to degrade ARE-containing mRNAs.</title>
<authorList>
<person name="Chen C.-Y."/>
<person name="Gherzi R."/>
<person name="Ong S.-E."/>
<person name="Chan E.L."/>
<person name="Raijmakers R."/>
<person name="Pruijn G.J.M."/>
<person name="Stoecklin G."/>
<person name="Moroni C."/>
<person name="Mann M."/>
<person name="Karin M."/>
</authorList>
<dbReference type="PubMed" id="11719186"/>
<dbReference type="DOI" id="10.1016/s0092-8674(01)00578-5"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>IDENTIFICATION IN THE RNA EXOSOME CORE COMPLEX</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2002" name="EMBO J." volume="21" first="165" last="174">
<title>The mammalian exosome mediates the efficient degradation of mRNAs that contain AU-rich elements.</title>
<authorList>
<person name="Mukherjee D."/>
<person name="Gao M."/>
<person name="O'Connor J.P."/>
<person name="Raijmakers R."/>
<person name="Pruijn G."/>
<person name="Lutz C.S."/>
<person name="Wilusz J."/>
</authorList>
<dbReference type="PubMed" id="11782436"/>
<dbReference type="DOI" id="10.1093/emboj/21.1.165"/>
</citation>
<scope>FUNCTION IN ARE-CONTAINING MRNA-BINDING AND CYTOPLASMIC MRNA DEGRADATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2006" name="Mol. Cell" volume="21" first="437" last="443">
<title>Adenylation and exosome-mediated degradation of cotranscriptionally cleaved pre-messenger RNA in human cells.</title>
<authorList>
<person name="West S."/>
<person name="Gromak N."/>
<person name="Norbury C.J."/>
<person name="Proudfoot N.J."/>
</authorList>
<dbReference type="PubMed" id="16455498"/>
<dbReference type="DOI" id="10.1016/j.molcel.2005.12.008"/>
</citation>
<scope>FUNCTION IN NUCLEAR PRE-MRNA DEGRADATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2006" name="RNA" volume="12" first="1810" last="1816">
<title>Sequence-specific RNA binding mediated by the RNase PH domain of components of the exosome.</title>
<authorList>
<person name="Anderson J.R."/>
<person name="Mukherjee D."/>
<person name="Muthukumaraswamy K."/>
<person name="Moraes K.C."/>
<person name="Wilusz C.J."/>
<person name="Wilusz J."/>
</authorList>
<dbReference type="PubMed" id="16912217"/>
<dbReference type="DOI" id="10.1261/rna.144606"/>
</citation>
<scope>FUNCTION</scope>
<scope>ARE BINDING</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2007" name="RNA" volume="13" first="1027" last="1035">
<title>Human cell growth requires a functional cytoplasmic exosome, which is involved in various mRNA decay pathways.</title>
<authorList>
<person name="van Dijk E.L."/>
<person name="Schilders G."/>
<person name="Pruijn G.J."/>
</authorList>
<dbReference type="PubMed" id="17545563"/>
<dbReference type="DOI" id="10.1261/rna.575107"/>
</citation>
<scope>FUNCTION IN MRNA DEGRADATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-306; SER-392 AND SER-394</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-306</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-297</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2010" name="EMBO J." volume="29" first="2358" last="2367">
<title>Dis3-like 1: a novel exoribonuclease associated with the human exosome.</title>
<authorList>
<person name="Staals R.H."/>
<person name="Bronkhorst A.W."/>
<person name="Schilders G."/>
<person name="Slomovic S."/>
<person name="Schuster G."/>
<person name="Heck A.J."/>
<person name="Raijmakers R."/>
<person name="Pruijn G.J."/>
</authorList>
<dbReference type="PubMed" id="20531389"/>
<dbReference type="DOI" id="10.1038/emboj.2010.122"/>
</citation>
<scope>IDENTIFICATION IN THE RNA EXOSOME COMPLEX</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-306; SER-392 AND SER-394</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-306</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2013" name="Genes Dev." volume="27" first="2227" last="2232">
<title>A SUMO-dependent interaction between Senataxin and the exosome, disrupted in the neurodegenerative disease AOA2, targets the exosome to sites of transcription-induced DNA damage.</title>
<authorList>
<person name="Richard P."/>
<person name="Feng S."/>
<person name="Manley J.L."/>
</authorList>
<dbReference type="PubMed" id="24105744"/>
<dbReference type="DOI" id="10.1101/gad.224923.113"/>
</citation>
<scope>INTERACTION WITH SETX</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF 388-PRO--LEU-391; 390-ILE-LEU-391 AND 395-GLU--GLU-398</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65 AND SER-306</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-306 AND SER-346</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-409 AND SER-411 (ISOFORM 2)</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-325 AND SER-327 (ISOFORM 4)</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-297</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="12432" last="12437">
<title>Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.</title>
<authorList>
<person name="Impens F."/>
<person name="Radoshevich L."/>
<person name="Cossart P."/>
<person name="Ribet D."/>
</authorList>
<dbReference type="PubMed" id="25114211"/>
<dbReference type="DOI" id="10.1073/pnas.1413825111"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-297</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2015" name="Cell Rep." volume="10" first="1778" last="1791">
<title>SUMO-2 orchestrates chromatin modifiers in response to DNA damage.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Treffers L.W."/>
<person name="Verlaan-de Vries M."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25772364"/>
<dbReference type="DOI" id="10.1016/j.celrep.2015.02.033"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-297</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1419" last="1434">
<title>System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.</title>
<authorList>
<person name="Xiao Z."/>
<person name="Chang J.G."/>
<person name="Hendriks I.A."/>
<person name="Sigurdsson J.O."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25755297"/>
<dbReference type="DOI" id="10.1074/mcp.o114.044792"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-297 AND LYS-419</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-297 AND LYS-419</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2018" name="Am. J. Hum. Genet." volume="102" first="858" last="873">
<title>Variants in EXOSC9 disrupt the RNA exosome and result in cerebellar atrophy with spinal motor neuronopathy.</title>
<authorList>
<person name="Burns D.T."/>
<person name="Donkervoort S."/>
<person name="Mueller J.S."/>
<person name="Knierim E."/>
<person name="Bharucha-Goebel D."/>
<person name="Faqeih E.A."/>
<person name="Bell S.K."/>
<person name="Alfaifi A.Y."/>
<person name="Monies D."/>
<person name="Millan F."/>
<person name="Retterer K."/>
<person name="Dyack S."/>
<person name="MacKay S."/>
<person name="Morales-Gonzalez S."/>
<person name="Giunta M."/>
<person name="Munro B."/>
<person name="Hudson G."/>
<person name="Scavina M."/>
<person name="Baker L."/>
<person name="Massini T.C."/>
<person name="Lek M."/>
<person name="Hu Y."/>
<person name="Ezzo D."/>
<person name="Alkuraya F.S."/>
<person name="Kang P.B."/>
<person name="Griffin H."/>
<person name="Foley A.R."/>
<person name="Schuelke M."/>
<person name="Horvath R."/>
<person name="Boennemann C.G."/>
</authorList>
<dbReference type="PubMed" id="29727687"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2018.03.011"/>
</citation>
<scope>INVOLVEMENT IN PCH1D</scope>
<scope>VARIANTS PCH1D PRO-14 AND 161-ARG--ASN-439 DEL</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2006" name="Cell" volume="127" first="1223" last="1237">
<title>Reconstitution, activities, and structure of the eukaryotic RNA exosome.</title>
<authorList>
<person name="Liu Q."/>
<person name="Greimann J.C."/>
<person name="Lima C.D."/>
</authorList>
<dbReference type="PubMed" id="17174896"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.10.037"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.35 ANGSTROMS)</scope>
<scope>LACK OF CATALYTIC ACTIVITY</scope>
<scope>RECONSTITUTION OF THE RNA EXOSOME CORE COMPLEX</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2007" name="Cell" volume="131" first="188" last="189">
<authorList>
<person name="Liu Q."/>
<person name="Greimann J.C."/>
<person name="Lima C.D."/>
</authorList>
</citation>
<scope>ERRATUM OF PUBMED:17174896</scope>
</reference>
<reference key="32" evidence="2 3">
<citation type="journal article" date="2018" name="Cell" volume="173" first="1663" last="1677.e21">
<title>Helicase-Dependent RNA Decay Illuminated by a Cryo-EM Structure of a Human Nuclear RNA Exosome-MTR4 Complex.</title>
<authorList>
<person name="Weick E.M."/>
<person name="Puno M.R."/>
<person name="Januszyk K."/>
<person name="Zinder J.C."/>
<person name="DiMattia M.A."/>
<person name="Lima C.D."/>
</authorList>
<dbReference type="PubMed" id="29906447"/>
<dbReference type="DOI" id="10.1016/j.cell.2018.05.041"/>
</citation>
<scope>STRUCTURE BY ELECTRON MICROSCOPY (3.45 ANGSTROMS)</scope>
<scope>SUBUNIT</scope>
</reference>
<comment type="function">
<text evidence="17 19 20 21">Non-catalytic component of the RNA exosome complex which has 3'-&gt;5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. The catalytic inactive RNA exosome core complex of 9 subunits (Exo-9) is proposed to play a pivotal role in the binding and presentation of RNA for ribonucleolysis, and to serve as a scaffold for the association with catalytic subunits and accessory proteins or complexes. EXOSC9 binds to ARE-containing RNAs.</text>
</comment>
<comment type="subunit">
<text evidence="16 18 22 23 25">Component of the RNA exosome complex (PubMed:29906447). Specifically part of the catalytically inactive RNA exosome core (Exo-9) complex which is believed to associate with catalytic subunits EXOSC10, and DIS3 or DIS3L in cytoplasmic- and nuclear-specific RNA exosome complex forms. Exo-9 is formed by a hexameric ring of RNase PH domain-containing subunits specifically containing the heterodimers EXOSC4-EXOSC9, EXOSC5-EXOSC8 and EXOSC6-EXOSC7, and peripheral S1 domain-containing components EXOSC1, EXOSC2 and EXOSC3 located on the top of the ring structure (PubMed:11719186, PubMed:12788944, PubMed:20531389). Interacts (via C-terminus region) with SETX (via N-terminus domain); the interaction enhances SETX sumoylation (PubMed:24105744).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-347966">
<id>Q06265</id>
</interactant>
<interactant intactId="EBI-371823">
<id>Q9NPD3</id>
<label>EXOSC4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="17">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="23">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="23">Nucleus</location>
<location evidence="23">Nucleolus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="23">Nucleus</location>
<location evidence="23">Nucleoplasm</location>
</subcellularLocation>
<text evidence="23">Colocalizes with SETX in nuclear foci upon induction of transcription-related DNA damage at the S phase (PubMed:24105744).</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 1</molecule>
<subcellularLocation>
<location>Nucleus</location>
<location>Nucleolus</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 2</molecule>
<subcellularLocation>
<location>Nucleus</location>
<location>Nucleolus</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 3</molecule>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<text>Excluded from the nucleolus.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q06265-1</id>
<name>1</name>
<name>PM/SCL-75c-alpha</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q06265-2</id>
<name>2</name>
<name>PM/SCL-75c-beta</name>
<sequence type="described" ref="VSP_025556"/>
</isoform>
<isoform>
<id>Q06265-3</id>
<name>3</name>
<name>PM/SCL-75a-alpha</name>
<sequence type="described" ref="VSP_025555"/>
</isoform>
<isoform>
<id>Q06265-4</id>
<name>4</name>
<name>PM/SCL-75a-beta</name>
<sequence type="described" ref="VSP_025555 VSP_025556"/>
</isoform>
</comment>
<comment type="disease" evidence="24">
<disease id="DI-05293">
<name>Pontocerebellar hypoplasia 1D</name>
<acronym>PCH1D</acronym>
<description>An autosomal recessive neurologic disorder with onset at birth or in infancy, and characterized by progressive axonal motor neuronopathy, severe generalized hypotonia, respiratory insufficiency, and cerebellar atrophy. Death in childhood may occur.</description>
<dbReference type="MIM" id="618065"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="29">Belongs to the RNase PH family.</text>
</comment>
<comment type="caution">
<text evidence="29">The six exosome core subunits containing a RNase PH-domain are not phosphorolytically active.</text>
</comment>
<dbReference type="EMBL" id="M58460">
<property type="protein sequence ID" value="AAA58384.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U09215">
<property type="protein sequence ID" value="AAA18832.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ505989">
<property type="protein sequence ID" value="CAD44530.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ517294">
<property type="protein sequence ID" value="CAD56889.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC079341">
<property type="protein sequence ID" value="AAY40968.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS34057.1">
<molecule id="Q06265-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS3722.2">
<molecule id="Q06265-1"/>
</dbReference>
<dbReference type="PIR" id="G01425">
<property type="entry name" value="G01425"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001029366.1">
<molecule id="Q06265-2"/>
<property type="nucleotide sequence ID" value="NM_001034194.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005024.2">
<molecule id="Q06265-1"/>
<property type="nucleotide sequence ID" value="NM_005033.2"/>
</dbReference>
<dbReference type="PDB" id="2NN6">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.35"/>
<property type="chains" value="A=1-302"/>
</dbReference>
<dbReference type="PDB" id="6D6Q">
<property type="method" value="EM"/>
<property type="resolution" value="3.45"/>
<property type="chains" value="A=1-439"/>
</dbReference>
<dbReference type="PDB" id="6D6R">
<property type="method" value="EM"/>
<property type="resolution" value="3.45"/>
<property type="chains" value="A=1-439"/>
</dbReference>
<dbReference type="PDB" id="6H25">
<property type="method" value="EM"/>
<property type="resolution" value="3.80"/>
<property type="chains" value="A=1-439"/>
</dbReference>
<dbReference type="PDBsum" id="2NN6"/>
<dbReference type="PDBsum" id="6D6Q"/>
<dbReference type="PDBsum" id="6D6R"/>
<dbReference type="PDBsum" id="6H25"/>
<dbReference type="SMR" id="Q06265"/>
<dbReference type="BioGRID" id="111402">
<property type="interactions" value="85"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-476">
<property type="entry name" value="Nuclear exosome complex, DIS3-EXOSC10 variant"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-591">
<property type="entry name" value="Nucleolar exosome complex, EXOSC10 variant"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-592">
<property type="entry name" value="Cytoplasmic exosome complex, DIS3L variant"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-593">
<property type="entry name" value="Exosome complex, DIS3 variant"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-600">
<property type="entry name" value="Cytoplasmic exosome complex, DIS3L-EXOSC10 variant"/>
</dbReference>
<dbReference type="CORUM" id="Q06265"/>
<dbReference type="DIP" id="DIP-31286N"/>
<dbReference type="IntAct" id="Q06265">
<property type="interactions" value="49"/>
</dbReference>
<dbReference type="MINT" id="Q06265"/>
<dbReference type="STRING" id="9606.ENSP00000368984"/>
<dbReference type="iPTMnet" id="Q06265"/>
<dbReference type="PhosphoSitePlus" id="Q06265"/>
<dbReference type="SwissPalm" id="Q06265"/>
<dbReference type="BioMuta" id="EXOSC9"/>
<dbReference type="DMDM" id="147744559"/>
<dbReference type="EPD" id="Q06265"/>
<dbReference type="jPOST" id="Q06265"/>
<dbReference type="MassIVE" id="Q06265"/>
<dbReference type="MaxQB" id="Q06265"/>
<dbReference type="PaxDb" id="Q06265"/>
<dbReference type="PeptideAtlas" id="Q06265"/>
<dbReference type="PRIDE" id="Q06265"/>
<dbReference type="ProteomicsDB" id="58426">
<molecule id="Q06265-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="58427">
<molecule id="Q06265-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="58428">
<molecule id="Q06265-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="58429">
<molecule id="Q06265-4"/>
</dbReference>
<dbReference type="Antibodypedia" id="26749">
<property type="antibodies" value="139 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000243498">
<molecule id="Q06265-1"/>
<property type="protein sequence ID" value="ENSP00000243498"/>
<property type="gene ID" value="ENSG00000123737"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000379663">
<molecule id="Q06265-2"/>
<property type="protein sequence ID" value="ENSP00000368984"/>
<property type="gene ID" value="ENSG00000123737"/>
</dbReference>
<dbReference type="GeneID" id="5393"/>
<dbReference type="KEGG" id="hsa:5393"/>
<dbReference type="UCSC" id="uc003idz.4">
<molecule id="Q06265-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5393"/>
<dbReference type="DisGeNET" id="5393"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000123737.12"/>
<dbReference type="GeneCards" id="EXOSC9"/>
<dbReference type="HGNC" id="HGNC:9137">
<property type="gene designation" value="EXOSC9"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000123737">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="EXOSC9"/>
<dbReference type="MIM" id="606180">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="618065">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q06265"/>
<dbReference type="OpenTargets" id="ENSG00000123737"/>
<dbReference type="Orphanet" id="2254">
<property type="disease" value="Pontocerebellar hypoplasia type 1"/>
</dbReference>
<dbReference type="PharmGKB" id="PA33463"/>
<dbReference type="eggNOG" id="KOG1614">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00950000183130"/>
<dbReference type="HOGENOM" id="CLU_038194_7_0_1"/>
<dbReference type="InParanoid" id="Q06265"/>
<dbReference type="KO" id="K03678"/>
<dbReference type="OMA" id="HGEICQI"/>
<dbReference type="OrthoDB" id="996662at2759"/>
<dbReference type="PhylomeDB" id="Q06265"/>
<dbReference type="TreeFam" id="TF300092"/>
<dbReference type="PathwayCommons" id="Q06265"/>
<dbReference type="Reactome" id="R-HSA-380994">
<property type="pathway name" value="ATF4 activates genes in response to endoplasmic reticulum stress"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-429958">
<property type="pathway name" value="mRNA decay by 3' to 5' exoribonuclease"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-450385">
<property type="pathway name" value="Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-450513">
<property type="pathway name" value="Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-450604">
<property type="pathway name" value="KSRP (KHSRP) binds and destabilizes mRNA"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6791226">
<property type="pathway name" value="Major pathway of rRNA processing in the nucleolus and cytosol"/>
</dbReference>
<dbReference type="SIGNOR" id="Q06265"/>
<dbReference type="BioGRID-ORCS" id="5393">
<property type="hits" value="615 hits in 876 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="EXOSC9">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q06265"/>
<dbReference type="GeneWiki" id="Exosome_component_9"/>
<dbReference type="GenomeRNAi" id="5393"/>
<dbReference type="Pharos" id="Q06265">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q06265"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 4"/>
</dbReference>
<dbReference type="RNAct" id="Q06265">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000123737">
<property type="expression patterns" value="Expressed in female gonad and 234 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q06265">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q06265">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000177">
<property type="term" value="C:cytoplasmic exosome (RNase complex)"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000178">
<property type="term" value="C:exosome (RNase complex)"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000228">
<property type="term" value="C:nuclear chromosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000176">
<property type="term" value="C:nuclear exosome (RNase complex)"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005730">
<property type="term" value="C:nucleolus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000175">
<property type="term" value="F:3'-5'-exoribonuclease activity"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0017091">
<property type="term" value="F:AU-rich element binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0035925">
<property type="term" value="F:mRNA 3'-UTR AU-rich region binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001102">
<property type="term" value="F:RNA polymerase II activating transcription factor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043928">
<property type="term" value="P:exonucleolytic catabolism of deadenylated mRNA"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000467">
<property type="term" value="P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006955">
<property type="term" value="P:immune response"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071028">
<property type="term" value="P:nuclear mRNA surveillance"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071042">
<property type="term" value="P:nuclear polyadenylation-dependent mRNA catabolic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0071035">
<property type="term" value="P:nuclear polyadenylation-dependent rRNA catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071038">
<property type="term" value="P:nuclear polyadenylation-dependent tRNA catabolic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0000956">
<property type="term" value="P:nuclear-transcribed mRNA catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034427">
<property type="term" value="P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0030307">
<property type="term" value="P:positive regulation of cell growth"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043488">
<property type="term" value="P:regulation of mRNA stability"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016075">
<property type="term" value="P:rRNA catabolic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006364">
<property type="term" value="P:rRNA processing"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0034473">
<property type="term" value="P:U1 snRNA 3'-end processing"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0034475">
<property type="term" value="P:U4 snRNA 3'-end processing"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0034476">
<property type="term" value="P:U5 snRNA 3'-end processing"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="CDD" id="cd11368">
<property type="entry name" value="RNase_PH_RRP45"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.230.70">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR001247">
<property type="entry name" value="ExoRNase_PH_dom1"/>
</dbReference>
<dbReference type="InterPro" id="IPR015847">
<property type="entry name" value="ExoRNase_PH_dom2"/>
</dbReference>
<dbReference type="InterPro" id="IPR036345">
<property type="entry name" value="ExoRNase_PH_dom2_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR027408">
<property type="entry name" value="PNPase/RNase_PH_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR020568">
<property type="entry name" value="Ribosomal_S5_D2-typ_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR033100">
<property type="entry name" value="Rrp45"/>
</dbReference>
<dbReference type="Pfam" id="PF01138">
<property type="entry name" value="RNase_PH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF03725">
<property type="entry name" value="RNase_PH_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF54211">
<property type="entry name" value="SSF54211"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55666">
<property type="entry name" value="SSF55666"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0271">Exosome</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0523">Neurodegeneration</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0694">RNA-binding</keyword>
<keyword id="KW-0698">rRNA processing</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Exosome complex component RRP45" id="PRO_0000139971">
<location>
<begin position="1"/>
<end position="439"/>
</location>
</feature>
<feature type="region of interest" description="ARE binding" evidence="20">
<location>
<begin position="1"/>
<end position="268"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="65"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="5">
<location>
<position position="297"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 6 7 8 9 10">
<location>
<position position="306"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="346"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 7">
<location>
<position position="392"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 7">
<location>
<position position="394"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="11">
<location>
<position position="297"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="12 13 14 15">
<location>
<position position="297"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="13 15">
<location>
<position position="419"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3 and isoform 4." id="VSP_025555" evidence="27 28">
<location>
<begin position="1"/>
<end position="84"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 4." id="VSP_025556" evidence="26 28">
<original>Q</original>
<variation>QELGFHHVGQTGLEFLTS</variation>
<location>
<position position="385"/>
</location>
</feature>
<feature type="sequence variant" description="In PCH1D; reduced EXOSC9 and exosome levels in patient cells; dbSNP:rs139632595." id="VAR_081052" evidence="24">
<original>L</original>
<variation>P</variation>
<location>
<position position="14"/>
</location>
</feature>
<feature type="sequence variant" description="In PCH1D; reduced EXOSC9 and exosome levels in patient cells." id="VAR_081053" evidence="24">
<location>
<begin position="161"/>
<end position="439"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1803183." id="VAR_051867">
<original>I</original>
<variation>V</variation>
<location>
<position position="366"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1051881." id="VAR_014924">
<original>S</original>
<variation>T</variation>
<location>
<position position="425"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with SETX." evidence="23">
<original>PIIL</original>
<variation>EECP</variation>
<location>
<begin position="388"/>
<end position="391"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with SETX." evidence="23">
<location>
<begin position="388"/>
<end position="391"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with SETX." evidence="23">
<location>
<begin position="390"/>
<end position="391"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with SETX." evidence="23">
<original>EEEE</original>
<variation>AAAA</variation>
<location>
<begin position="395"/>
<end position="398"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with SETX." evidence="23">
<location>
<begin position="395"/>
<end position="398"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="8"/>
<end position="19"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="24"/>
<end position="26"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="36"/>
<end position="39"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="45"/>
<end position="52"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="54"/>
<end position="59"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="62"/>
<end position="64"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="69"/>
<end position="72"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="76"/>
<end position="82"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="84"/>
<end position="86"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="92"/>
<end position="94"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="96"/>
<end position="99"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="101"/>
<end position="113"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="118"/>
<end position="121"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="122"/>
<end position="124"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="125"/>
<end position="127"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="128"/>
<end position="138"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="146"/>
<end position="159"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="165"/>
<end position="168"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="171"/>
<end position="174"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="176"/>
<end position="179"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="191"/>
<end position="198"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="200"/>
<end position="202"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="203"/>
<end position="208"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="211"/>
<end position="216"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="220"/>
<end position="226"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="227"/>
<end position="229"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="230"/>
<end position="238"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="244"/>
<end position="277"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="284"/>
<end position="286"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="287"/>
<end position="290"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="291"/>
<end position="298"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location sequence="Q06265-2">
<position position="409"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location sequence="Q06265-2">
<position position="411"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location sequence="Q06265-4">
<position position="325"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location sequence="Q06265-4">
<position position="327"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2NN6"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6D6Q"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6D6R"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25114211"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25755297"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25772364"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11719186"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11782436"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12788944"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16455498"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16912217"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17545563"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20531389"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24105744"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29727687"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29906447"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="12788944"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="2007859"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000303">
<source ref="2"/>
</evidence>
<evidence key="29" type="ECO:0000305"/>
<sequence length="439" mass="48949" checksum="7E27322F094ED3F3" modified="2007-05-15" version="3">MKETPLSNCERRFLLRAIEEKKRLDGRQTYDYRNIRISFGTDYGCCIVELGKTRVLGQVSCELVSPKLNRATEGILFFNLELSQMAAPAFEPGRQSDLLVKLNRLMERCLRNSKCIDTESLCVVAGEKVWQIRVDLHLLNHDGNIIDAASIAAIVALCHFRRPDVSVQGDEVTLYTPEERDPVPLSIHHMPICVSFAFFQQGTYLLVDPNEREERVMDGLLVIAMNKHREICTIQSSGGIMLLKDQVLRCSKIAGVKVAEITELILKALENDQKVRKEGGKFGFAESIANQRITAFKMEKAPIDTSDVEEKAEEIIAEAEPPSEVVSTPVLWTPGTAQIGEGVENSWGDLEDSEKEDDEGGGDQAIILDGIKMDTGVEVSDIGSQDAPIILSDSEEEEMIILEPDKNPKKIRTQTTSAKQEKAPSKKPVKRRKKKRAAN</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

